Biorce

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Biorce is a medtech startup that develops a clinical AI assistant to enhance clinical trials for both speed and cost efficiency.

HQ Location

Barcelona (Spain)

Founded

2024

Employees

11 - 50

Total funding raised

$61.53M

Funding Status

Series A, $51.99M, February 2, 2026

Clinical trials take 11 years and cost $6.2B to bring a drug to market.

57% face costly protocol amendments that add months of delay.



We're changing that.



Aika is the first explainable AI assistant purpose-built for clinical protocol design, specialized with 560,000+ real trials to help biotech, pharma and CROs design smarter protocols faster.



The impact:

→ 50% faster protocol development

→ $200K-$400K saved per avoided amendment

→ Regulatory-ready outputs from day one



Every recommendation is backed by verifiable sources. Every decision stays with clinical experts.



Faster trials don't mean riskier ones. With Aika, they mean smarter ones.



Built by clinical experts, for clinical experts.